SCHEMBL6049345

SCHEMBL6049345

CCCCC(c1cccc(O)c1)c1ccc2[nH]c(C(=O)OC(C)(C)C)cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.39
FLT3 P36888 4/20 0.39
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 1/20 0.38
CLK1 P49759 1/20 0.38
DYRK1A Q13627 1/20 0.38
SMAD3 P84022 1/20 0.38
SRC P12931 1/20 0.37
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
NPC1 O15118 2/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MMP2 P08253 1/20 0.36
MMP13 P45452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6049272 0.76 GABRA1 (0.39) HRH3FLT3KDM4EALDH1A1HPGD
SCHEMBL6049346 0.74 SRC (0.47) FLT3KDM4EALDH1A1HPGDRAB9A
SCHEMBL6049273 0.69 SRC (0.41) FLT3KDM4EALDH1A1HPGDRAB9A
SCHEMBL832227 0.68 RAB9A (0.67) HRH3FLT3KDM4EALDH1A1HPGD
SCHEMBL29496122 0.68 KDM4E (0.63) FLT3KDM4EALDH1A1HPGDRAB9A
SCHEMBL318243 0.68 KDM4E (0.63) FLT3KDM4EALDH1A1HPGDRAB9A
SCHEMBL5795136 0.68 KDM4E (0.48) HRH3KDM4EALDH1A1HPGDRAB9A
SCHEMBL4666737 0.67 F7 (0.60) HRH3FLT3RAB9ANPC1PDGFRB
SCHEMBL7493127 0.67 FLT3 (0.57) HRH3FLT3KDM4EALDH1A1HPGD
SCHEMBL3494717 0.67 HRH4 (0.51) HRH3FLT3KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264480-A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same SUH YOUNG G 2006-11-23 US disclosed
US-20030203944-A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same PACIFIC CORPORATION (KR) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264480-A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same TRPV1, TRPA1, TRPV5 HRH3 222/4885FLT3 4044/4885KDM4E 4307/4885
US-20030203944-A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same TRPV1, TRPA1, TRPV5 HRH3 222/4885FLT3 4044/4885KDM4E 4307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.